CRISPR Therapeutics AG (CRSP) Payables (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Payables of $11.31 million for Q2 2026, up 15.9% from $9.75 million a year earlier but down 17.1% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, CRISPR Therapeutics AG posted Payables of $11.14 million, down 24.3% from FY2024.
- Payables has a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
- By year, Payables came in at $14.71 million in FY2024 (-61.4%), $38.15 million in FY2023 (+39.1%), $27.43 million in FY2022 (+85.1%) and $14.82 million in FY2021 (+62.9%).
- Five-year quarterly Payables spans a low of $9.45 million in Q2 2024 and a high of $45.15 million in Q1 2023.
- Year over year, Payables gained in three of the last eight quarters, with an average decline of 18.4%.
- The high point for year-over-year Payables in five years was Q3 2022 (growth of 215.9%); the low point was Q2 2024 (a decline of 65.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.65 million (Q1 2026), $11.14 million (Q4 2025) and $11.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 11.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31 Mn |
| Mar 31, 2026 | 13.65 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 9.75 Mn |
| Mar 31, 2025 | 13.06 Mn |
| Dec 31, 2024 | 14.71 Mn |
| Sep 30, 2024 | 15.58 Mn |
| Jun 30, 2024 | 9.45 Mn |
| Mar 31, 2024 | 16.46 Mn |
| Dec 31, 2023 | 38.15 Mn |
| Sep 30, 2023 | 26.15 Mn |
| Jun 30, 2023 | 27.59 Mn |
| Mar 31, 2023 | 45.15 Mn |
| Dec 31, 2022 | 27.43 Mn |
| Sep 30, 2022 | 32.11 Mn |
| Jun 30, 2022 | 25.24 Mn |
| Mar 31, 2022 | 27.11 Mn |
| Dec 31, 2021 | 14.82 Mn |
| Sep 30, 2021 | 10.17 Mn |
API Access
CRISPR Therapeutics AG Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();